Key Highlights
- KeyBanc initiated coverage with an Overweight rating and $135 price target, suggesting approximately 40% potential upside
- Company confirmed for Nasdaq-100 Index addition starting June 22, 2026
- Neutron rocket program continues on track for inaugural flight this year following resolution of January testing issue
- First quarter revenue reached $200.35 million, reflecting 63.4% growth year-over-year and surpassing analyst projections of $189.65 million
- Institutional investors control 71.78% of shares, with several major funds expanding holdings during Q1
Rocket Lab (RKLB) shares closed at $102.39 on Monday, posting a 6.50% gain as Wall Street analysts upgrade their outlook and the company secures a coveted spot in a major market index.
KeyBanc initiated coverage of RKLB with an Overweight rating while establishing a $135 price target. This valuation implies approximately 40% upside potential from current trading levels. The firm maintained its existing financial forecasts.
The rating arrives as Rocket Lab gears up for its Nasdaq-100 debut, scheduled for June 22. Such index additions typically trigger substantial buying activity from the more than 200 investment vehicles that replicate the index, representing collective assets exceeding $800 billion.
KeyBanc highlighted Rocket Lab’s standing as the commercial space launch industry’s second-largest competitor. The company’s Electron rocket has successfully completed approximately 90 missions to date.
For many market watchers, the Neutron rocket represents the more compelling narrative. KeyBanc noted improved clarity regarding the program during the last six months and verified that a January testing setback has been completely addressed. Neutron remains scheduled for its maiden launch within the current year.
Stifel recently elevated its RKLB price objective to $132 from $110, reaffirming its Buy recommendation based on robust revenue growth and an expanding contract pipeline.
First Quarter Performance Exceeds Expectations
On May 7, Rocket Lab disclosed Q1 revenue of $200.35 million, surpassing analyst forecasts of $189.65 million. This figure represented a 63.4% increase compared to the prior-year quarter.
Earnings per share registered at -$0.07, aligning with Wall Street expectations. The business recorded a net margin of negative 26.87% alongside a negative return on equity of 11.72%. Full-year EPS projections stand at -$0.29.
Shares have skyrocketed more than 300% over the trailing twelve months. The stock reached a 52-week peak of $151.00 and touched a low of $25.24, currently trading approximately 24% beneath its high. The 50-day moving average stands at $101.62.
Institutional Ownership Continues to Expand
Institutional investors hold 71.78% of outstanding RKLB shares. During Q1, AQR Capital Management more than doubled its stake, purchasing 92,849 additional shares. NewEdge Advisors expanded its position by over 1,800%. UBS Asset Management acquired 90,758 shares, elevating its total holdings to 773,548.
Entropy Technologies LP grew its investment by 18.5% in Q4, bringing its stake to 55,117 shares valued at approximately $3.85 million.
Regarding insider transactions, Director Alexander Slusky disposed of 100,000 shares on May 12 at $118.08 per share, decreasing his holdings by 18.7%. Insider Marvin Bradford Clevenger sold 15,549 shares on May 26 at $142.57, with the transaction attributed to tax liabilities associated with vesting equity compensation.
Wall Street sentiment remains predominantly bullish. Among analysts covering the stock, twelve assign a Buy rating, three issue a Strong Buy, five recommend Hold, and one suggests Sell. The consensus price target is established at $102.76.
The stock has additionally gained from heightened interest in the space industry following SpaceX’s recent Nasdaq listing, prompting investors to rotate capital into space-focused equities.
